Lung Cancer Nexus
Congresses
Stay ahead on key advances in non–small-cell lung cancer (NSCLC) and small-cell lung cancer (SCLC), with updates from the major oncology congresses. Browse articles and expert videos to support interpretation of the latest evidence and evolving treatment strategies.
ASCO 2026: HARMONi-6 results in first-line NSCLC
Check out phase 3 HARMONi-6 results from ASCO 2026 showing improved overall survival with ivonescimab plus chemotherapy in advanced squamous NSCLC.
ASCO 2026: CROWN study. Lorlatinib in ALK+ NSCLC
Explore 7-year CROWN data from ASCO 2026 showing durable lorlatinib benefit in ALK+ NSCLC, including long-term CNS control and safety outcomes.